According to a survey released by Tufts Center for the Study of Drug Development, ‘2017 eClinical Landscape Study’, the length of time it takes companies to build and release a clinical study database is having a negative effect on trial completion
Here, Michael Merges, Catalent Biologics, and Brian Fahie, Biogen, discuss the growing need for partners who can provide niche technologies to accelerate development projects.
Ampoules are a traditional type of primary packaging for pharmaceutical drugs that offer a good choice for emerging markets. Here, Lothar Haaf and Dr Volker Rekowski discuss the benefits of this product.
Facts and figures published by the manufacturers’ organisation, EEF, and Santander show that British manufacturing has climbed up the global rankings to now be the eighth largest industrial nation.
Data published by the BioIndustry Association (BIA) has revealed that most healthcare professionals are not aware of government-led initiatives, such as the Accelerated Access Review, aimed at improving innovation adoption across the NHS.
Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space?
The US Food and Drug Administration (FDA) has issued a warning letter to Meridian Medical Technologies, concerning the manufacture of epinephrine auto injectors.
The latest report from business information and analytics provider, GlobalData, has indicated that immune-oncology (IO) will become the fifth pillar of cancer treatment, joining surgery, radiotherapy, chemotherapy and other targeted treatments.
President of FIP, Dr Carmen Peña, has stated investment in the pharma sector is required to ensure universal health coverage, at the opening of the 77th World Congress of Pharmacy and Pharmaceutical Sciences in Seoul, Republic of Korea.
In this next instalment of our ‘Meet the maker’ series, we talk with Wendy Dwyer who was recently appointed as chief business officer of Portal Instruments — a Series B funded, clinical stage medical device company focused on advanced drug delivery.
Recent research from serialisation software provider, SEA Vision, and life sciences technology firm, Zenith Technologies, has revealed that for the majority of industry professionals the cost of implementing serialisation is the biggest barrier
